XML 50 R39.htm IDEA: XBRL DOCUMENT v3.19.1
BUSINESS ACQUISITIONS - Narrative (Details)
€ in Millions, £ in Millions
3 Months Ended
Apr. 29, 2019
EUR (€)
Apr. 29, 2019
USD ($)
Apr. 03, 2018
USD ($)
Jan. 11, 2018
USD ($)
Mar. 30, 2019
USD ($)
Mar. 30, 2019
GBP (£)
Mar. 31, 2018
USD ($)
Sep. 29, 2018
USD ($)
Sep. 29, 2018
GBP (£)
Mar. 26, 2018
USD ($)
Jan. 11, 2018
GBP (£)
Credit facility | $2.3 Billion Credit Facility                      
Business Acquisition [Line Items]                      
Credit facility                   $ 2,300,000,000.0  
Citoxlab                      
Business Acquisition [Line Items]                      
Integration related costs and transaction costs         $ 5,200,000            
MPI Research                      
Business Acquisition [Line Items]                      
Purchase price     $ 829,700,000                
Integration related costs and transaction costs         100,000   $ 2,700,000        
Purchase price allocation     800,800,000                
Cash acquired     27,700,000                
Adjustments related to prior period     1,200,000                
Goodwill, amount expected to be deductible for tax purposes     $ 4,100,000                
Weighted average amortization life of intangible assets acquired     12 years                
MPI Research | Client relationships                      
Business Acquisition [Line Items]                      
Weighted average amortization life of intangible assets acquired     13 years                
KWS BioTest Limited                      
Business Acquisition [Line Items]                      
Purchase price       $ 20,300,000              
Integration related costs and transaction costs         100,000   400,000        
Purchase price allocation       21,529,000              
Cash acquired       1,000,000              
Adjustments related to prior period       $ 400,000              
Undiscounted contingent payments               $ 2,600,000 £ 2.0   £ 3.0
Payments for contingent liabilities         $ 2,600,000 £ 2.0          
KWS BioTest Limited | Client relationships                      
Business Acquisition [Line Items]                      
Weighted average amortization life of intangible assets acquired         12 years 12 years          
Depreciation and Amortization Expense | MPI Research                      
Business Acquisition [Line Items]                      
Adjustments related to prior period             6,900,000        
Interest expense | MPI Research                      
Business Acquisition [Line Items]                      
Adjustments related to prior period             $ 2,600,000        
Subsequent Event | Citoxlab                      
Business Acquisition [Line Items]                      
Purchase price € 448 $ 500,000,000